Trial · NCT03170271
Results by group52
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 52
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Annualized Rate of Asthma Exacerbations Over the Treatment Period (up to Week 24) | Benralizumab | 0.94 | 95% Confidence Interval 0.79 to 1.12 | Events/year | |
| Annualized Rate of Asthma Exacerbations Over the Treatment Period (up to Week 24) | Placebo | 1.86 | 95% Confidence Interval 1.54 to 2.24 | Events/year | |
| Change From Baseline in Saint George Respiratory Questionnaire (SGRQ) Total Score to the EOT (Week 24) | Benralizumab | -23.06 | Standard Error 1.00 | Scores on a scale | |
| Change From Baseline in Saint George Respiratory Questionnaire (SGRQ) Total Score to the EOT (Week 24) | Placebo | -14.94 | Standard Error 1.34 | Scores on a scale | |
| Change From Baseline in Pre-Bronchodilator (BD) Forced Expiratory Volume in First Second (FEV1) to the EOT (Week 24) | Benralizumab | 0.30 | Standard Error 0.02 | Liters (L) | |
| Change From Baseline in Pre-Bronchodilator (BD) Forced Expiratory Volume in First Second (FEV1) to the EOT (Week 24) | Placebo | 0.14 | Standard Error 0.03 | Liters (L) | |
| Change From Baseline in Asthma Control Questionnaire 6 (ACQ-6) Score to the EOT (Week 24) | Benralizumab | -1.47 | Standard Error 0.06 | Scores on a scale | |
| Change From Baseline in Asthma Control Questionnaire 6 (ACQ-6) Score to the EOT (Week 24) | Placebo | -1.01 | Standard Error 0.08 | Scores on a scale | |
| Time to First Asthma Exacerbation (up to Week 24) | Benralizumab | 123 | Participants | ||
| Time to First Asthma Exacerbation (up to Week 24) | Placebo | 107 | Participants | ||
| Change From Run-in Baseline Home Peak Expiratory Flow (PEF) (Morning and Evening) to the EOT (Week 24) | Benralizumab | Morning | 27.17 | Standard Error 3.98 | L/minute |
| Change From Run-in Baseline Home Peak Expiratory Flow (PEF) (Morning and Evening) to the EOT (Week 24) | Placebo | Morning | 7.06 | Standard Error 5.49 | L/minute |
| Change From Run-in Baseline Home Peak Expiratory Flow (PEF) (Morning and Evening) to the EOT (Week 24) | Benralizumab | Evening | 16.47 | Standard Error 4.04 | L/minute |
| Change From Run-in Baseline Home Peak Expiratory Flow (PEF) (Morning and Evening) to the EOT (Week 24) | Placebo | Evening | -6.61 | Standard Error 5.54 | L/minute |
| Change From Baseline in Short Form 36-item Health Survey, Version 2 (SF-36v2) to the EOT (Week 24) | Benralizumab | Physical functioning | 17.76 | Standard Error 1.21 | Scores on a scale |
| Change From Baseline in Short Form 36-item Health Survey, Version 2 (SF-36v2) to the EOT (Week 24) | Placebo | Physical functioning | 12.42 | Standard Error 1.59 | Scores on a scale |
| Change From Baseline in Short Form 36-item Health Survey, Version 2 (SF-36v2) to the EOT (Week 24) | Benralizumab | Role limitations due to physical health | 17.62 | Standard Error 1.34 | Scores on a scale |
| Change From Baseline in Short Form 36-item Health Survey, Version 2 (SF-36v2) to the EOT (Week 24) | Placebo | Role limitations due to physical health | 10.82 | Standard Error 1.76 | Scores on a scale |
| Change From Baseline in Short Form 36-item Health Survey, Version 2 (SF-36v2) to the EOT (Week 24) | Benralizumab | Bodily pain | 6.44 | Standard Error 1.37 | Scores on a scale |
| Change From Baseline in Short Form 36-item Health Survey, Version 2 (SF-36v2) to the EOT (Week 24) | Placebo | Bodily pain | 3.37 | Standard Error 1.79 | Scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03170271/results